Oxford Biomedica
Focus: Oxford Biomedica is a public CDMO specializing in AAV (adeno-associated virus) manufacturing and viral vector development for gene therapy applications. With 1,001–5,000 employees headquartered in Bedford, MA, the company serves as a critical manufacturing partner for advanced therapy developers.
Profile data last refreshed 14h ago · AI intelligence enriched 6d ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Oxford Biomedica
AI assessmentNot HiringNo open roles listed right now. Follow Oxford Biomedica to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Oxford Biomedica's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RetinoStat
Age-Related Macular DegenerationClinical Trials (1)
NCT01678872A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Phase 1Help build intelligence for Oxford Biomedica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.